Orthoplastics

What Orthoplastics does

Orthoplastics Ltd, founded in 1986 and headquartered in Bacup, Lancashire (UK), is a custom manufacturer of medical-grade Ultra-High-Molecular-Weight Polyethylene (UHMWPE) and adjacent implantable polymers for the global orthopaedic device industry. The company supplies premium UHMWPE, crosslinked UHMWPE, Vitamin E-stabilised UHMWPE, and more recently Hostaform MT®2U06 Acetal and Radel R-5500 PPSU, primarily to orthopaedic OEMs for hip, knee, shoulder, and spinal implants. Core manufacturing capabilities include Direct Compression Moulding, ram extrusion, X-ray crosslinking (developed with STERIS), precision CNC machining across 45 centres, and additive prototyping. Backed by an on-site UKAS-accredited laboratory, the company is a subsidiary of Viant and operates from a 145,000+ sq ft UK footprint with an additional Rossendale facility opened in 2020.

The business model is B2B enterprise contract manufacturing with direct OEM sales — Orthoplastics generates revenue through hardware sales of medical-grade polymers and precision-machined components, supplemented by professional services revenue from laboratory testing, R&D, design and engineering, and consultation. Pricing is custom-quoted based on material specifications, volume, and service requirements; no public pricing exists. The go-to-market is enterprise field sales via a dedicated Business Development team (including a recently hired EU BD Manager), reinforced by presence at major orthopaedic industry conferences such as AAOS, OMTEC, and the Implant Polymers UHMWPE & PEEK Conference. Customer concentration sits within a single vertical (orthopaedic OEMs) but across 350+ global accounts, with long regulatory-driven qualification cycles that produce high switching costs once Orthoplastics' materials are designed into an approved implant. The company holds ISO 13485, ISO/IEC 17025 (UKAS), FDA registration under 21 CFR Part 820, USP Class VI, and ISO 10993 certifications, and is led by Managing Director John Devine (appointed June 2026).

Name

Orthoplastics

Legal name

Orthoplastics Ltd

Website

https://orthoplastics.com

Company type

Private

Founded year

1986

Operating status

Operating

Short description

Orthoplastics is a UK-based custom manufacturer of medical-grade UHMWPE and adjacent implantable polymers, supplying over 350 global orthopaedic device OEMs with raw materials, precision-machined components, Direct Compression Moulding, and UKAS-accredited laboratory services for hip, knee, shoulder and spinal implants.

Ownership category

akta.pro rank

Product category

Medical-Grade Orthopaedic Polymers (Implantable UHMWPE and Biocompatible Plastics)

NAICS

Plastics and Rubber Products Manufacturing (326)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

Keywords

• Medical grade polymers
• Orthopaedic implant materials
• Implantable UHMWPE
• Precision plastic machining
• Direct compression moulding

Headquarters

HQ city

Bacup

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical-grade UHMWPE Sales: Manufacture and supply of premium implantable-grade UHMWPE, crosslinked UHMWPE, and Vitamin E-stabilised materials to orthopaedic device manufacturers. Revenue generated through sale of raw materials and processed components.
2. Component Machining Services: Precision CNC machining of orthopaedic components from UHMWPE and other medical-grade polymers. Services include one-off prototyping, pre-production validation runs, and full-scale manufacturing.
3. Laboratory and Testing Services: UKAS-accredited laboratory providing polymer testing, failure analysis, mechanical testing, chemical analysis, and custom R&D services. Supports CE marking and FDA 510(k) clearance submissions.
4. Direct Compression Moulding: Production of moulded orthopaedic components with high-gloss, polished surfaces for implant applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Orthoplastics is a custom manufacturer of medical-grade UHMWPE (Ultra-High-Molecular-Weight Polyethylene) and complementary implantable polymers (crosslinked UHMWPE, Vitamin E-stabilised UHMWPE, Radel R-5500 PPSU, Hostaform MT®2U06 Acetal), producing raw materials, precision CNC-machined components and Direct Compression Moulded parts for hip, knee, shoulder and spinal orthopaedic implants. The portfolio is rounded out by a UKAS-accredited laboratory offering testing, R&D and regulatory support and by technical services spanning consultation, research, design and engineering. Customers are orthopaedic device OEMs purchasing under custom commercial quotations.

Product overview

Orthoplastics is a world leader in medical-grade UHMWPE (Ultra-High-Molecular-Weight Polyethylene) and implantable plastics for orthopaedic devices. As a Viant company, they offer a comprehensive portfolio of products including standard UHMWPE, crosslinked UHMWPE, Vitamin E-stabilised UHMWPE, Radel® R-5500 PPSU, and Hostaform® MT®2U06 Acetal, complemented by Direct Compression Moulding and precision Component Machining capabilities. Their offering is supported by a UKAS-accredited laboratory providing testing, R&D, and quality assurance services. The portfolio serves the full orthopaedic supply chain from hip and knee replacements to shoulder and spinal implants.

Differentiator

Problem solved

Functional benefit

Brands

• Viant: Parent company brand identity - Orthoplastics operates as a Viant company

Products and services

• UHMWPE (Ultra-High-Molecular-Weight Polyethylene) Implantable-grade UHMWPE plastics engineered for hip, knee, shoulder and spinal implants, recognised as the world leader in the supply and manufacture of UHMWPE for the medical industry.
• Component Machining Precision CNC machining of individual orthopaedic components manufactured to customer specifications from UHMWPE and other implant-grade plastics, including prototyping, pre-production validation and full-scale production.
• Direct Compression Moulding Manufacture of orthopaedic implant components with highly polished, high-gloss finish on a direct moulded surface using advanced compression moulding techniques, enabling production of monoblock components.
• Crosslinked Polyethylene Crosslinked UHMWPE offering significant wear reduction and increased implant lifespan for orthopaedic applications, including a novel X-ray crosslinked variant produced using STERIS technology.
• Vitamin E UHMWPE Vitamin E enhanced UHMWPE that reduces oxidation, ensures consistent quality and delivers long-term benefits for implantable medical devices.
• Radel R-5500 PPSU High-strength Radel R-5500 polyphenylsulfone (PPSU) offering strength, sterilisation durability and design flexibility for reusable medical instruments and implant trials, withstanding over 1,000 autoclave cycles.
• Hostaform MT®2U06 Acetal Medical-grade Hostaform MT®2U06 acetal copolymer delivering certified biocompatibility, strength and sterilisation performance for high-quality orthopaedic instruments and medical devices.
• Laboratory Services UKAS-accredited laboratory providing polymer testing, research and development, failure analysis, and subcontracting services for medical device development.
• Consultation Services Expert consultation and laboratory access to help accelerate development, reduce costs and support every manufacturing stage for orthopaedic device customers.
• Research Services Innovative R&D delivering premium medical plastics to meet standards and drive breakthroughs in orthopaedic materials.
• Design & Engineering Services Advanced technologies and expert support turning complex orthopaedic designs into high-precision implant components.
• Testing & Laboratory Services UKAS-accredited laboratory ensuring rigorous testing, regulatory compliance and faster product development support for medical device customers.

Quantifiable outcome

• Manufacturing capacity increased by 75% with new extruder investment
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core and minor.

• STERIScoreStrategic or Co-development Partner · 1 October 2019Strategic partnership for development of novel X-ray technology for manufacturing highly crosslinked UHMWPE. STERIS developed new method to create high energy X-rays allowing sterilisation and chemical change in UHMWPE, deemed the long-term sustainable solution to Gamma processing.
• Lancaster UniversityminorStrategic or Co-development Partner · 1 January 2019Exploratory discussions initiated in 2019 for potential long-term collaborative partnership in research and development.
• Burnley CollegecoreStrategic or Co-development Partner · 1 January 2013Long-standing apprenticeship partnership with Burnley College. Over 10 years, 21 apprentices have successfully completed the program with over 70% remaining at the company. College provides first year off-the-job training for apprentices.

Scale indicators11 records

Recent moves9 records

Expansion highlights5 records

Peers

• Quadrant (Mitsubishi Chemical Advanced Materials):

Direct peers

• Invibio (Victrex): Invibio, a Victrex company, is the leading PEEK-based medical polymer supplier for implantable devices including spinal and orthopaedic applications. Directly comparable to Orthoplastics as a specialty implantable-grade polymer manufacturer serving orthopaedic OEMs, though focused on PEEK rather than UHMWPE. Notably, Orthoplastics' incoming MD John Devine previously led Invibio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/orthoplastics-ltd/about

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orthoplastics